What is the incidence of pericardial effusion in melanoma patients treated with nivolumab?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Pericardial effusion occurs in 7% of melanoma patients treated with ICIs, including nivolumab, but severe cases requiring intervention are less common, at around 0.61% for nivolumab specifically.
Fields of Study & Subjects
Pericarditis and Cardiac Tamponade
Cancer Immunotherapy and Biomarkers
Cardiac tumors and thrombi
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 16 March 2026
- Language
- EN